European Regulators to Investigate Illumina's $8 Billion Grail Deal - NewsBreak

San Diego life sciences company Illumina could face a hefty fine for completing its $8 billion takeover of cancer detection test maker Grail without first securing EU antitrust approval. Illumina closed the Grail takeover, completed via cash and stock, on Wednesday and said it would hold the company separate while...